Kenneth Lindegaard Madsen

Kenneth Lindegaard Madsen

Associate Professor - Promotion Programme


  1. 2020
  2. Published

    A high-affinity, bivalent PDZ domain inhibitor complexes PICK1 to alleviate neuropathic pain

    Christensen, N. R., De Luca, M., Lever, M. B., Richner, M., Hansen, A. B., Noes-Holt, G., Jensen, K. L., Rathje, M., Jensen, D. B., Erlendsson, S., Bartling, C. R. O., Ammendrup-Johnsen, I., Pedersen, S. E., Schönauer, M., Nissen, K. B., Midtgaard, S. R., Teilum, K., Arleth, L., Sørensen, A. T., Bach, A. & 5 others, Strømgaard, Kristian, Meehan, Claire Francesca, Vægter, C. B., Gether, Ulrik & Madsen, Kenneth Lindegaard, 2020, In: EMBO Molecular Medicine. 12, 6, 25 p., e11248.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Administration of a novel high affinity PICK1 PDZ domain inhibitor attenuates cocaine seeking in rats

    Turner, C., De Luca, M., Wolfheimer, J., Hernandez, N., Madsen, Kenneth Lindegaard & Schmidt, H. D., 2020, In: Neuropharmacology. 164, 107901.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Constitutive internalization across therapeutically targeted GPCRs correlates with constitutive activity

    Schmidt, Jan Hendrik, Perslev, Mathias, Bukowski, L., Stoklund, M., Herborg, Freja, Herlo, R. & Madsen, Kenneth Lindegaard, 2020, In: Basic & Clinical Pharmacology & Toxicology. 126, S6, p. 116-121 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 6404